Standout Papers

Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia 2023 2026 202451
  1. Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia (2023)
    Daniel Lee, M Słomkowski et al. JAMA Neurology

Immediate Impact

2 from Science/Nature 61 standout
Sub-graph 1 of 24

Citing Papers

Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
2024 Standout
Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study
2024 Standout
1 intermediate paper

Works of Eva Kohegyi being referenced

Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia
2023 Standout
Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials
2019

Author Peers

Author Last Decade Papers Cites
Eva Kohegyi 416 147 57 150 14 727
Dennis Sweitzer 652 140 43 192 13 801
Joseph Stringfellow 472 89 49 128 19 657
Saulo C. M. Ribeiro 290 94 38 233 10 772
B.I. Diamond 280 172 31 94 23 601
D. H. Wiles 566 135 84 74 26 793
Mei‐Chun Hsiao 199 142 33 126 37 737
Concetta D’Arrigo 455 157 169 186 14 793
I. Kurzthaler 446 93 38 120 30 679
Belmaker Rh 353 121 57 87 41 711
Silvia Paletta 368 106 54 121 26 641

All Works

Loading papers...

Rankless by CCL
2026